AMP-activated protein kinase and its regulation by adiponectin and interleukin-6

References

• NawrockiARRajalaMWTomasEPajvaniUBSahaAKTrumbauerME Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonistsJ Biol Chem2006281265460
   PubMed Web of Science ®Google Scholar
• FebbraioMAPedersenBK. Muscle-derived interleukin-6: mechanisms for activation and possible biological rolesFASEB J200216133547
   PubMed Web of Science ®Google Scholar
• KellyMKellerCAviluceaPRKellerPLuoZXiangX AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exerciseBiochem Biophys Res Commun200432044954
   PubMed Web of Science ®Google Scholar
• FaldtJWernstedtIFitzgeraldSMWalleniusKBergstromGJanssonJO. Reduced exercise endurance in interleukin-6-deficient miceEndocrinology200414526806
   PubMed Web of Science ®Google Scholar
• WalleniusVWalleniusKAhrenBRudlingMCarlstenHDicksonSL Interleukin-6-deficient mice develop mature-onset obesityNat Med20028759
   PubMed Web of Science ®Google Scholar
• ElhageRClamensSBesnardSMallatZTedguiAArnalJ Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17β-estradiol in apolipoprotein E-deficient miceAtherosclerosis200115631520
   PubMed Web of Science ®Google Scholar
• SchiefferBSelleTHilfikerAHilfiker-KleinerDGroteKTietgeUJ Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosisCirculation20041103493500
   PubMed Web of Science ®Google Scholar
• Ruderman NB, Shulman G. The metobolic syndrome. In: Jameson JL, ed. Endocrinology. 5th edn. Philadelphia PA: Elsevier; 2006 pp.1149–116.
   Google Scholar
• RudermanNPrentkiM. AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndromeNat Rev Drug Discov2004334051
   PubMed Web of Science ®Google Scholar
• CarlingD. The AMP-activated protein kinase cascade – a unifying system for energy controlTrends Biochem Sci2004291824
   PubMed Web of Science ®Google Scholar
• HawleySABoudeauJReidJLMustardKJUddLMakelaTP Complexes between the LKB1 tumor suppressor, STRAD α/β and MO25 α/β are upstream kinases in the AMP-activated protein kinase cascadeJ Biol2003228
   PubMedGoogle Scholar
• WoodsAJohnstoneSRDickersonKLeiperFCFryerLGNeumannD LKB1 is the upstream kinase in the AMP-activated protein kinase cascadeCurr Biol20031320048
   PubMed Web of Science ®Google Scholar
• WoodsADickersonKHeathRHongSPMomcilovicMJohnstoneSR Ca2+/calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cellsCell Metab200522133
   PubMed Web of Science ®Google Scholar
• HawleySAPanDAMustardKJRossLBainJEdelmanAM Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinaseCell Metab20052919
   PubMed Web of Science ®Google Scholar
• KahnBBAlquierTCarlingDHardieDG. AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolismCell Metab200511525
   PubMed Web of Science ®Google Scholar
• TsaoTSTomasEMurreyHEHugCLeeDHRudermanNB Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity. Different oligomers activate different signal transduction pathwaysJ Biol Chem2003278508107
   PubMed Web of Science ®Google Scholar
• KadowakiTYamauchiT. Adiponectin and adiponectin receptorsEndocr Rev20052643951
   PubMed Web of Science ®Google Scholar
• FruebisJTsaoTSJavorschiSEbbets-ReedDEricksonMRYenFT Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in miceProc Natl Acad Sci USA200198200510
   PubMed Web of Science ®Google Scholar
• TomasETsaoTSSahaAKMurreyHEZhang CcCItaniSI Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activationProc Natl Acad Sci USA2002991630913
   PubMed Web of Science ®Google Scholar
• WuXMotoshimaHMahadevKStalkerTJScaliaRGoldsteinBJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytesDiabetes200352135563
   PubMed Web of Science ®Google Scholar
• YamauchiTKamonJMinokoshiYItoYWakiHUchidaS Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinaseNat Med20028128895
   PubMed Web of Science ®Google Scholar
• CombsTPWagnerJABergerJDoebberTWangWJZhangBB Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists: a potential mechanism of insulin sensitizationEndocrinology20021439981007
   PubMed Web of Science ®Google Scholar
• XuAWangYKeshawHXuLYLamKSCooperGJ. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in miceJ Clin Invest200311291100
   PubMed Web of Science ®Google Scholar
• OkamotoYKiharaSOuchiNNishidaMAritaYKumadaM Adiponectin reduces atherosclerosis in apolipoprotein E-deficient miceCirculation2002106276770
   PubMed Web of Science ®Google Scholar
• OuchiNKiharaSAritaYMaedaKKuriyamaHOkamotoY Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectinCirculation199910024736
   PubMed Web of Science ®Google Scholar
• OuchiNKiharaSAritaYOkamotoYMaedaKKuriyamaH Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathwayCirculation20001021296301
   PubMed Web of Science ®Google Scholar
• CacicedoJMYagihashiNKeaneyJFJrRudermanNBIdoY. AMPK inhibits fatty acid-induced increases in NF-κB transactivation in cultured human umbilical vein endothelial cellsBiochem Biophys Res Commun200432412049
   PubMed Web of Science ®Google Scholar
• SahaAKAviluceaPRYeJMAssifiMMKraegenEWRudermanNB. Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivoBiochem Biophys Res Commun20043145805
   PubMed Web of Science ®Google Scholar
• NakaTNishimotoNKishimotoT. The paradigm of IL-6: from basic science to medicineArthritis Res20024Suppl 3S23342
   PubMedGoogle Scholar
• Ruderman NB, Keller C, Richard A, Saha AK, Luo Z, Xiang X, . Interleukin-6 regulation of AMPK: potential role in the systemic response to exercise and prevention of the metabolic syndrome. Diabetes 2006; ( in press).
   Google Scholar
• ParkHKaushikVKConstantSPrentkiMPrzybytkowskiERudermanNB Coordinate regulation of malonyl-CoA decarboxylase, sn-glycerol-3-phosphate acyltransferase, and acetyl-CoA carboxylase by AMP-activated protein kinase in rat tissues in response to exerciseJ Biol Chem2002277325717
   PubMed Web of Science ®Google Scholar
• OstrowskiKRohdeTZachoMAspSPedersenBK. Evidence that interleukin-6 is produced in human skeletal muscle during prolonged runningJ Physiol199850894953
   PubMed Web of Science ®Google Scholar
• OstrowskiKSchjerlingPPedersenBK. Physical activity and plasma interleukin-6 in humans – effect of intensity of exerciseEur J Appl Physiol2000835125
   PubMed Web of Science ®Google Scholar
• van HallGSteensbergASacchettiMFischerCKellerCSchjerlingP Interleukin-6 stimulates lipolysis and fat oxidation in humansJ Clin Endocrinol Metab200388300510
   PubMed Web of Science ®Google Scholar
• PedersenBKSteensbergASchjerlingP. Muscle-derived interleukin-6: possible biological effectsJ Physiol200153632937
   PubMed Web of Science ®Google Scholar
• SteensbergAKellerCStarkieRLOsadaTFebbraioMAPedersenBK. IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscleAm J Physiol Endocrinol Metab2002283E12728
   PubMed Web of Science ®Google Scholar
• MuJBrozinickJTJrValladaresOBucanMBirnbaumMJ. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscleMol Cell20017108594
   PubMed Web of Science ®Google Scholar